Open AccessClinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation
Author(s) -
Tianxiang Zhang,
Wěi Li,
Meng Gu,
Ziyu Wang,
Shijie Zhou,
Xuefeng Hao,
Shaofa Xu
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s305179
Subject(s) - lung cancer , microrna , downregulation and upregulation , adenocarcinoma , medicine , non small cell lung cancer (nsclc) , oncology , clinical significance , real time polymerase chain reaction , cancer research , lung , carcinoma , pathology , cancer , biology , a549 cell , gene , biochemistry
Accumulating evidence has indicated that dysregulated microRNAs (miRNAs) are involved in cancer progression. In this study, we evaluated the clinicopathologic significance of miR-183-3p and miR-182-5p, and the role of miR-183-3p in non-small-cell lung cancer (NSCLC) progression.